CANbridge Pharmaceuticals Inc.

HKEX:1228.HK

0.195 (HKD) • At close November 14, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

20232022202120202019
Operating Activities:
Net Income -378.837-483.475-1,077.006-846.043-217.675
Depreciation & Amortization 28.4621.97815.70617.8393.595
Deferred Income Tax 033.565-42.20723.2973.557
Stock Based Compensation 19.91726.82230.5114.65516.69
Change In Working Capital 28.081118.94923.01945.999-9.735
Accounts Receivables -12.174-9.913-2.101-6.603-0.193
Inventory 1.0413.624-12.8950.066-3.02
Accounts Payables 09.9132.1016.6030.193
Other Working Capital 39.214115.32535.91445.933-6.715
Other Non Cash Items 24.1481.182462.908592.60577.393
Operating Cash Flow -278.231-280.979-587.07-151.648-126.175
Investing Activities:
Investments In Property Plant And Equipment -5.144-34.786-5.332-153.483-42.476
Acquisitions Net 000041.396
Purchases Of Investments 0000-12
Sales Maturities Of Investments 000012
Other Investing Activites -21.711-19.589131.426-150.912-41.34
Investing Cash Flow -26.855-34.786126.094-153.483-42.42
Financing Activities:
Debt Repayment -25.968-4.675-3.7457.28459.5
Common Stock Issued 0.0760.034563.8040.9850
Common Stock Repurchased 00000
Dividends Paid 00000
Other Financing Activities -2.125-16.063294.251670.99437.467
Financing Cash Flow -28.017-20.704854.31679.26396.967
Other Information:
Effect Of Forex Changes On Cash 6.84741.811-8.323-27.2010.261
Net Change In Cash -326.256-294.658385.011346.931-71.367
Cash At End Of Period 124.901451.157745.815360.80413.873